% decrease. The promising growth of non-SW revenue was from IPD (49% growth) followed by OPD (14% growth) yoy. Both number of patients and revenue per head of 4Q19 increased. The higher revenue per head

June 30, 2016 and the six-month period ended June 30, 2017, respectively. The figures represent a period-on-period decrease of 2.51% due mainly to an unusual high of patients from influenza epidemics in

zone increased from movement sold to EGR Australia to EGR Europe as delivery country. Gross profit margin decreased 5% duted to sold OEM project that high gross profit margin decrease, gross profit of

Polymer business unit was risen by 2.67%. And the sales value of Specialty Chemicals business unit was decreased by 32.05%. The 4.79% decrease in total sales revenue was mainly due to the decline in sales

and its subsidiary’s net profits resulted from the growth of revenue, the decrease in the proportion of the cost of hospital operations to the total revenue and the decrease in financing cost. Statement

profit of THB 93 million the same period of previous year, representing a decrease of 37%. The details were, as followings; (1) Thai Sugar Business, the company recorded the performance from normal

recorded average selling price increase from 14,939 THB/ton to 17,362 THB/ton or increased by 16%. However the Company recorded sales volume decrease from 875,841 tons to 687,046 tons and marked to market

margin in 2017 was 30%, which is considered high compared to other competitors, although it is lower than the previous year. The decrease was due to the impact of a change in foreign currency exchange

2019 and 2018 Unit: Million Baht Q1’2019 Q1’2018 Increase (Decrease) % Change Sales income 15,399.76 14,874.75 525.01 3.53% Rental and service income 657.95 599.32 58.62 9.78% Other income 495.30 426.26

was dropped by 1.45%. And the sales value of Specialty Chemicals business unit was decreased by 16.63%. The 5.09% decrease in total sales revenue was mainly due to the decline in selling price resulting